CBRS Is Surging. Read the Fine Print First.

Eighty-six percent.

That is the share of Cerebras Systems’ 2025 revenue tied to two UAE-linked entities. G42 and MBZUAI. While the stock is moving nearly 20% today, trading around $240 off a prior close of $201.01, that number sits quietly in the S-1 and almost nobody is leading with it. U.S.-billed revenue actually declined 34% last year. The OpenAI deal above $20 billion and the AWS term sheet from March are real, but they are future revenue, not current revenue. That distinction matters more than the intraday move does.

Here is what the growth story actually looks like underneath all of this. $24.6 million in revenue in 2022. $510 million in 2025. That is a genuine tenfold increase in three years, and the 76% year-over-year growth from $290.3 million in 2024 is not the kind of number you construct with accounting tricks. The growth is real. The reported GAAP net income of $237.8 million is less clean — it includes a one-time non-cash gain of roughly $363.5 million. Back that out and the operating loss was $145.9 million in 2025. Worth knowing before you size anything.

What’s interesting is the architecture conversation tends to get more airtime than the financials. The WSE-3 is legitimately different — 4 trillion transistors, 900,000 cores on a single wafer, on-chip interconnects that sidestep the off-die latency problem Nvidia GPU clusters still carry. On low-batch inference workloads, Cerebras claims 2,100 tokens per second on Llama 3 70B versus roughly 500 to 700 on a single H100. That gap is real in specific use cases. It is not a universal performance story. Nvidia’s CUDA ecosystem took two decades to build and it is not going anywhere.

Nine analysts cover CBRS. Average 12-month target is $290.56. The stock has already traded from its $185 IPO price to an all-time high of $386.34 and back down to $196.73 on June 5. That range — less than four weeks of trading history — tells you everything about the volatility embedded in this name. At $240 the market cap sits around $53 billion against $510 million in 2025 revenue. That is north of 100x price-to-sales. The $24.6 billion backlog is the bull case. The TSMC wafer supply running on purchase orders with no long-term commitment is the part of the backlog story that does not get equal time.

Volume today is running above the daily average of 5 million shares. That is not purely retail. The $240 to $248 zone is where the stock has found resistance in its short public life. Whether it holds there into the close or fades is the only real question for today.

Next earnings drop September 2, 2026.

By then the customer concentration question either starts resolving or it does not. That is the only thing that changes the longer-term picture here. The architecture is not the variable. The revenue mix is.

For informational and educational purposes only. Not investment advice. Trading involves risk, including loss of principal.